Guggenheim Downgrades Spring Works Therapeutics (SWTX) to Neutral
Tweet Send to a Friend
Guggenheim analyst Michael Schmidt downgraded Spring Works Therapeutics (NASDAQ: SWTX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
